In an IoT system, the sheer volume of data generated by numerous sensing devices necessitates a well-designed scheme for storing and retrieving data efficiently, enabling streamlined data processing and analytics. One promising storage architecture involves utilizing solid-state drives (SSDs) to cache data from hard disk drives (HDDs), thereby creating an SSD-based caching storage system. To further enhance access performance, it is possible to employ readahead techniques to minimize data access latency. However, the existing Linux readahead scheme falls short in fully leveraging SSD-based caching storage systems. We address this limitation by introducing a novel cross-layered readahead architecture that effectively communicates with the VFS layer, the file system layer, and the block I/O layer. This communication facilitates the acquisition of readahead timing, readahead data continuity, and readahead data location, respectively. To guide prefetching decisions, our architecture analyzes the degree of data access sequentiality, the performance model of the target storage device, and the access patterns of the I/O workload on the corresponding storage device. The implementation of this new architecture in the Linux kernel yields promising experimental results, demonstrating its robustness by consistently outperforming the stock Linux kernel. Notably, our architecture reduces the total execution time of the stock Linux kernel by up to 49%, except in cases of random workloads where both the stock Linux kernel and our architecture exhibit similar performance.

Echinococcus granulosus is a harmful cestode parasite which could cause Cystic Echinococcosis in humans, various livestock species and wild animals. Calmodulin (CaM), a Ca²⁺ sensor protein, is widely expressed in eukaryotes and mediates a variety of cellular signaling activities. In our study, the CaM in Echinococcus granulosus (rEgCaM) was successfully cloned and the molecular and biochemical characterizations of rEgCaM were identified. The results showed that rEgCaM was a highly conserved calcium-binding protein, consisting of 149 amino acids. Immunoblot analysis revealed that rEgCaM could be identified using E. granulosus infected sheep serum. The usage of rEgCaM as antigen was evaluated by indirect ELISA which exhibited a high sensitivity of 90.3% but low specificity (47.1%). rEgCaM was mainly located in the tegument tissues and parenchymal region of protoscoleces, the tegument and inner body of adult worm and predominantly expressed in the germinal layer. The mRNA expression of rEgCaM in PSCs were gradually decreased with the increase death of PSCs. In electrophoretic mobility tests and ANS assays, rEgCaM showed a typical calcium-binding protein characteristics. This is the first report on CaM from E. granulosus and rEgCaM is considered to be involved in some important biological function of E. granulosus as a calcium-binding protein.

Breast cancer is the most common malignancies in women and the second leading cause of cancer death in women. Triple negative breast cancer (TNBC) subtype is a breast cancer subset without ER, PR and HER2 expression, limiting treatment options and presenting a poorer survival rate. Thus, we investigated whether HDACi would be used as potential anti-cancer therapy on breast cancer cells. In this study, we found TNBC and HER2-enrich breast cancers are extremely sensitive to Panobinostat, Belinostat of HDACi via experiments of cell viability assay, apoptotic marker identification and flow cytometry measurement. On the other hand, we developed a bioluminescence based live cell non-invasive apoptosis detection sensor (IADS) detection system to evaluate the quantitative and kinetic analyses of apoptotic cell death by HDAC treatment on breast cancer cells. In addition, the use of HDACi may also be accompanied with chemotherapeutic agent such as doxorubicin to synergic drug sensitivity on TNBC cell (MDA-MB-231), but not in breast normal epithelia cells (MCF-10A), providing therapeutic benefits against breast tumor in clinic.